| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_784ace1f940b2df97948ade8ada4ed02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69 |
| filingDate |
2019-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce371a7c205729a3476748066d4e8a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f9698709bd9f51a5c23e5ace610d175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38fc046ff0fd38ea268fffc5a1053912 |
| publicationDate |
2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020073642-A1 |
| titleOfInvention |
Use of indirubin compound and bortezomib in preparing drug for treating multiple myeloma |
| abstract |
The present invention relates to the fields of medicine and pharmaceutics and sets forth a use of an indirubin compound and bortezomib in preparing a drug for treating multiple myeloma. The present invention has found that an indirubin compound is effective on patients resistant to bortezomib. A drug in which indirubin and bortezomib are used in combination has low toxicity, and the amount of bortezomib is reduced. |
| priorityDate |
2018-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |